Bai Zongxia, Nie Danyao, Zhang Jing, Hu Huiling, Sun Liangnan, Zeng Kun, Wang Jiantao, Liu Xinhua
The Second Clinical Medical College, Jinan University (Shenzhen Eye Hospital), Shenzhen, China.
Ann Transl Med. 2022 Feb;10(4):194. doi: 10.21037/atm-22-107.
To investigate the short-term visual function of the V4c implantable collamer lens (ICL) for myopia using a Binoptometer 4P.
Eighty eyes from 40 patients (age, 28.75±6.57 years) who underwent ICL V4c implantation at Shenzhen Eye Hospital from August 2020 to June 2021 were enrolled. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), subjective manifest refraction, intraocular pressure (IOP), and corneal endothelial cell density (ECD) were evaluated 1 month after surgery. Corrected distance visual acuity (CDVA), corrected near visual acuity (CNVA), contrast sensitivity (CS), near stereoacuity (NSA), twilight vision, and glare sensitivity were measured using a Binoptometer 4P.
The average logMAR (logarithmic minimum angle of resolution) UCVA postoperative was 0.07±0.13, which was significantly better than the preoperative BCVA (P=0.028). At 1 month postoperatively, the mean safety and efficacy indexes were 1.14±0.24 and 0.98±0.16, respectively. The mean spherical equivalent (SE) of all eyes was -8.98±3.20 D preoperatively, and -0.16±0.48 D postoperatively. None of the patients lost one or more lines of BCVA, 62.1% remained unchanged, 10.6% gained one line, and 27.3% gained two or more lines. CDVA, CNVA, CS, and NSA of both eyes were measured using a Binoptometer 4P, which were significantly better than the preoperative values. In addition, some patients had subjective symptoms in the early postoperative period, such as halo, glare, etc.
ICL V4c implantation is a safe, effective, and predictable solution for myopia. We found that the short-term visual function of patients was improved significantly. The Binoptometer 4P is an effective and convenient visual testing device for assessing postoperative visual function after ICL V4c implantation.
使用双目验光仪4P研究V4c型可植入式接触镜(ICL)矫正近视的短期视觉功能。
纳入2020年8月至2021年6月在深圳眼科医院接受ICL V4c植入术的40例患者(年龄28.75±6.57岁)的80只眼。术后1个月评估裸眼视力(UCVA)、最佳矫正视力(BCVA)、主观显验光、眼压(IOP)和角膜内皮细胞密度(ECD)。使用双目验光仪4P测量矫正远视力(CDVA)、矫正近视力(CNVA)、对比敏感度(CS)、近立体视锐度(NSA)、微光视力和眩光敏感度。
术后平均logMAR(对数最小分辨角)UCVA为0.07±0.13,显著优于术前BCVA(P = 0.028)。术后1个月,平均安全性和有效性指数分别为1.14±0.24和0.98±0.16。所有眼术前平均等效球镜度(SE)为-8.98±3.20 D,术后为-0.16±0.48 D。无患者BCVA下降一行或多行,62.1%保持不变,10.6%提高一行,27.3%提高两行或更多行。使用双目验光仪4P测量的双眼CDVA、CNVA、CS和NSA均显著优于术前值。此外,部分患者术后早期有主观症状,如光晕、眩光等。
ICL V4c植入术是一种安全、有效且可预测的近视矫正方案。我们发现患者的短期视觉功能有显著改善。双目验光仪4P是评估ICL V4c植入术后视觉功能的一种有效且便捷的视觉检测设备。